MyD88 is dispensable for cerebral amyloidosis and neuroinflammation in APP/PS1 transgenic mice

American Journal of Pathology

Volumn 184, Issue 11, 2014, Pages 2855-2861

  Weitz, Tara M ^a   Gate, David ^a   Rezai Zadeh, Kavon ^b   Town, Terrence ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID PRECURSOR PROTEIN; CHEMOKINE RECEPTOR CX3CR1; MYELOID DIFFERENTIATION FACTOR 88; MYD88 PROTEIN, MOUSE; PRESENILIN 1;

AMYLOID PLAQUE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASTROCYTOSIS; BRAIN HOMOGENATE; BRAIN REGION; CELL ACTIVATION; CEREBRAL BETA AMYLOIDOSIS; CHEMICAL ANALYSIS; COHORT ANALYSIS; DENSITOMETRY; FEMALE; GLIOSIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; TRANSGENIC MOUSE; VASCULAR AMYLOIDOSIS; WESTERN BLOTTING; ALZHEIMER DISEASE; ANIMAL; BRAIN CORTEX; DISEASE MODEL; GENETICS; KNOCKOUT MOUSE; METABOLISM; MICROGLIA; PATHOLOGY;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; CEREBRAL AMYLOID ANGIOPATHY; CEREBRAL CORTEX; DISEASE MODELS, ANIMAL; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; MICROGLIA; MYELOID DIFFERENTIATION FACTOR 88; PRESENILIN-1;

EID: 84908179190     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2014.07.004     Document Type: Article

References (27)

1. T.M. Weitz, and T. Town Microglia in Alzheimer's disease: it's all about context Int J Alzheimers Dis 2012 2012 314185
2. T. Town, V. Nikolic, and J. Tan The microglial "activation" continuum: from innate to adaptive responses J Neuroinflammation 2 2005 24
3. M. Lotz, S. Ebert, H. Esselmann, A.I. Iliev, M. Prinz, N. Wiazewicz, J. Wiltfang, J. Gerber, and R. Nau Amyloid beta peptide 1-40 enhances the action of Toll-like receptor-2 and -4 agonists but antagonizes Toll-like receptor-9-induced inflammation in primary mouse microglial cell cultures J Neurochem 94 2005 289 298
4. K. Tahara, H.D. Kim, J.J. Jin, J.A. Maxwell, L. Li, and K. Fukuchi Role of toll-like receptor signaling in Abeta uptake and clearance Brain 129 Pt 11 2006 3006 3019
5. C.R. Balistreri, M.P. Grimaldi, M. Chiappelli, F. Licastro, L. Castiglia, F. Listì, S. Vasto, D. Lio, C. Caruso, and G. Candore Association between the polymorphisms of TLR4 and CD14 genes and Alzheimer's disease Curr Pharm Des 14 2008 2672 2677
6. K.L. Richard, M. Filali, P. Préfontaine, and S. Rivest Toll-like receptor 2 acts as a natural innate immune receptor to clear amyloid beta 1-42 and delay the cognitive decline in a mouse model of Alzheimer's disease J Neurosci 28 2008 5784 5793
7. M. Jana, C.A. Palencia, and K. Pahan Fibrillar amyloid-beta peptides activate microglia via TLR2: implications for Alzheimer's disease J Immunol 181 2008 7254 7262
8. S. Frank, E. Copanaki, G.J. Burbach, U.C. Müller, and T. Deller Differential regulation of toll-like receptor mRNAs in amyloid plaque-associated brain tissue of aged APP23 transgenic mice Neurosci Lett 453 2009 41 44
9. E.G. Reed-Geaghan, J.C. Savage, A.G. Hise, and G.E. Landreth CD14 and toll-like receptors 2 and 4 are required for fibrillar A{beta}-stimulated microglial activation J Neurosci 29 2009 11982 11992
10. H. Scholtzova, R.J. Kascsak, K.A. Bates, A. Boutajangout, D.J. Kerr, H.C. Meeker, P.D. Mehta, D.S. Spinner, and T. Wisniewski Induction of toll-like receptor 9 signaling as a method for ameliorating Alzheimer's disease-related pathology J Neurosci 29 2009 1846 1854
11. M. Song, J. Jin, J.E. Lim, J. Kou, A. Pattanayak, J.A. Rehman, H.D. Kim, K. Tahara, R. Lalonde, and K. Fukuchi TLR4 mutation reduces microglial activation, increases Aβ deposits and exacerbates cognitive deficits in a mouse model of Alzheimer's disease J Neuroinflammation 8 2011 92
12. J.E. Lim, J. Kou, M. Song, A. Pattanayak, J. Jin, R. Lalonde, and K. Fukuchi MyD88 deficiency ameliorates β-amyloidosis in an animal model of Alzheimer's disease Am J Pathol 179 2011 1095 1103
13. Y. Doi, T. Mizuno, Y. Maki, S. Jin, H. Mizoguchi, M. Ikeyama, M. Doi, M. Michikawa, H. Takeuchi, and A. Suzumura Microglia activated with the toll-like receptor 9 ligand CpG attenuate oligomeric amyloid betaneurotoxicity in in vitro and in vivo models of Alzheimer's disease Am J Pathol 175 2009 2121 2132
14. K. Tahara, H.D. Kim, J.J. Jin, J.A. Maxwell, L. Li, K. Fukuchi, P. Iribarren, K. Chen, J. Hu, W. Gong, E.H. Cho, S. Lockett, B. Uranchimeg, and J.M. Wang CpG-containing oligodeoxynucleotide promotes microglial cell uptake of amyloid β 1-42 peptide by up-regulating the expression of the G-protein-coupled receptor mFPR2 FASEB J 19 2005 2032 2034
15. K. Chen, P. Iribarren, J. Hu, J. Chen, W. Gong, E.H. Cho, S. Lockett, N.M. Dunlop, and J.M. Wang Activation of Toll-like receptor 2 on microglia promotes cell uptake of Alzheimer disease-associated amyloid β peptide J Biol Chem 281 2006 3651 3659
16. J.P. Michaud, K.L. Richard, and S. Rivest MyD88-adaptor protein acts as a preventive mechanism for memory deficits in a mouse model of Alzheimer's disease Mol Neurodegener 6 2011 5
17. J. Tan, T. Town, F. Crawford, T. Mori, A. DelleDonne, R. Crescentini, D. Obregon, R.A. Flavell, and M.J. Mullan Role of CD40 ligand in amyloidosis in transgenic Alzheimer's mice Nat Neurosci 5 2002 1288 1293
18. T. Town, Y. Laouar, C. Pittenger, T. Mori, C.A. Szekely, J. Tan, R.S. Duman, and R.A. Flavell Blocking TGF-beta-Smad2/3 innate immune signaling mitigates Alzheimer-like pathology Nat Med 14 2008 681 687
19. K. Johnson-Wood, M. Lee, R. Motter, K. Hu, G. Gordon, R. Barbour, K. Khan, M. Gordon, H. Tan, D. Games, I. Lieberburg, D. Schenk, P. Seubert, and L. McConlogue Amyloid precursor protein processing and a-beta(42) deposition in a transgenic mouse model of Alzheimer disease Proc Natl Acad Sci U S A 94 1997 1550 1555
20. R. Kayed, and C.G. Glabe Conformation-dependent anti-amyloid oligomer antibodies Methods Enzymol 413 2006 326 344
21. R. Kayed, E. Head, J.L. Thompson, T.M. McIntire, S.C. Milton, C.W. Cotman, and C.G. Glabe Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis Science 300 2003 486 489
22. S. Lee, N.H. Varvel, M.E. Konerth, G. Xu, A.E. Cardona, R.M. Ransohoff, and B.T. Lamb CX3CR1 deficiency alters microglial activation and reduces beta-amyloid deposition in two Alzheimer's disease mouse models Am J Pathol 177 2010 2549 2562
23. Z. Liu, C. Condello, A. Schain, R. Harb, and J. Grutzendler CX3CR1 in microglia regulates brain amyloid deposition through selective protofibrillar amyloid-β phagocytosis J Neurosci 30 2010 17091 17101
24. Y. Liu, S. Walter, M. Stagi, D. Cherny, M. Letiembre, W. Schulz-Schaeffer, H. Heine, B. Penke, H. Neumann, and K. Fassbender LPS receptor (CD14): a receptor for phagocytosis of Alzheimer's amyloid peptide Brain 128 2005 1778 1789
25. M. Fiala, P. Liu, A. Espinosa-Jeffery, M. Rosenthal, G. Bernard, J. Ringman, M. Sayre, L. Zhang, J. Zaghi, S. Dejbakhsh, B. Chiang, J. Hui, M. Mahanian, A. Baghaee, P. Hong, and J. Cashman Innate immunity and transcription of MGAT-III and Toll-like receptors in Alzheimer's disease patients are improved by bisdemethoxycurcumin Proc Natl Acad Sci U S A 104 2007 12849 12854
26. G.E. Landreth, and E.G. Reed-Geaghan Toll-like receptors in Alzheimer's disease Curr Top Microbiol Immunol 336 2009 137 153
27. J.E. Lim, M. Song, J. Jin, J. Kou, A. Pattanayak, R. Lalonde, and K. Fukuchi The effects of MyD88 deficiency on exploratory activity, anxiety, motor coordination, and spatial learning in C57BL/6 and APPswe/PS1dE9 mice Behav Brain Res 227 2012 36 42